Clinical Trials List
Protocol NumberMK-7119-001
Active
2021-09-01 - 2029-10-31
Phase II
Recruiting1
ICD-10C79.81
Secondary malignant neoplasm of breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9198.81
Secondary malignant neoplasm of breast
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Chun-Hui Lee Division of Hematology & Oncology
- Jui-Hung Tsai Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
- Zhu-Jun Loh Division of General Surgery
- 楊舜如 Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3 participants
-
Global
55 participants
